• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于因膀胱癌接受根治性膀胱切除术的 70 岁及以上高龄患者,围手术期死亡率显著增加。

Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.

机构信息

Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.

出版信息

Urology. 2011 Mar;77(3):660-6. doi: 10.1016/j.urology.2010.07.537. Epub 2011 Jan 22.

DOI:10.1016/j.urology.2010.07.537
PMID:21256568
Abstract

OBJECTIVES

To revisit whether the perioperative mortality differs between septuagenarian and octogenarian patients and younger patients in a large contemporary population-based cohort. The data from tertiary care centers have suggested that perioperative mortality after radical cystectomy is not considerably different in septuagenarian or octogenarian patients compared with younger patients. However, population-based data have stated otherwise.

METHODS

From 1988 to 2006, 12,722 radical cystectomies were performed for urothelial carcinoma of the urinary bladder in 17 Surveillance, Epidemiology, and End Results registries. Of those 12,722 patients, 4480 (35.2%) were aged 70-79 years and 1439 (11.3%) were aged ≥80 years. Univariate and multivariate logistic regression models tested the 90-day mortality after radical cystectomy. Covariates consisted of sex, race, year of surgery, Surveillance, Epidemiology, and End Results registry, and histologic grade and stage.

RESULTS

The overall 90-day mortality rate was 4% for the entire population, 2% for patients aged ≤69 years, 5.4% for septuagenarian patients, and 9.2% for octogenarian patients. In the multivariate logistic regression analyses, septuagenarian (odds ratio 2.80; P < .001) and octogenarian (odds ratio 5.02; P < .001) age increased the risk of 90-day mortality after radical cystectomy.

CONCLUSIONS

In the present population-based analysis, the perioperative mortality after radical cystectomy was three- and fivefold greater in the septuagenarian and octogenarian patients, respectively, which was greater than that in tertiary care centers. This information should be included in informed consent considerations.

摘要

目的

在一个大型的当代基于人群的队列中,重新评估 70 岁和 80 岁以上患者与年轻患者之间围手术期死亡率是否存在差异。来自三级护理中心的数据表明,与年轻患者相比,70 岁或 80 岁以上患者行根治性膀胱切除术的围手术期死亡率并没有显著差异。然而,基于人群的数据却给出了不同的结论。

方法

1988 年至 2006 年,17 个监测、流行病学和最终结果(SEER)登记处对 12722 例膀胱癌进行了根治性膀胱切除术。在这 12722 例患者中,4480 例(35.2%)年龄在 70-79 岁之间,1439 例(11.3%)年龄≥80 岁。单变量和多变量逻辑回归模型检测了根治性膀胱切除术后 90 天的死亡率。协变量包括性别、种族、手术年份、SEER 登记处以及组织学分级和分期。

结果

在整个人群中,90 天总死亡率为 4%,≤69 岁患者为 2%,70 岁患者为 5.4%,80 岁患者为 9.2%。在多变量逻辑回归分析中,70 岁(优势比 2.80;P<.001)和 80 岁(优势比 5.02;P<.001)年龄增加了根治性膀胱切除术后 90 天死亡的风险。

结论

在本基于人群的分析中,70 岁和 80 岁以上患者行根治性膀胱切除术后的围手术期死亡率分别增加了 3 倍和 5 倍,高于三级护理中心的数据。这些信息应包含在知情同意考虑中。

相似文献

1
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.对于因膀胱癌接受根治性膀胱切除术的 70 岁及以上高龄患者,围手术期死亡率显著增加。
Urology. 2011 Mar;77(3):660-6. doi: 10.1016/j.urology.2010.07.537. Epub 2011 Jan 22.
2
Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.编者按。对于接受根治性膀胱切除术治疗膀胱尿路上皮癌的七旬和八旬患者,围手术期死亡率显著更高。
Urology. 2011 Mar;77(3):666-7; author reply 667. doi: 10.1016/j.urology.2010.08.055.
3
Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.编者按。对于接受根治性膀胱切除术治疗膀胱尿路上皮癌的七旬和八旬患者,围手术期死亡率显著更高。
Urology. 2011 Mar;77(3):667-8. doi: 10.1016/j.urology.2010.08.053.
4
Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663).回复:利伯曼等人:对于接受根治性膀胱切除术治疗膀胱尿路上皮癌的七旬和八旬患者,围手术期死亡率显著更高(《泌尿外科》2011年;77:660 - 663)。
Urology. 2011 Aug;78(2):486-7; author reply 487-8. doi: 10.1016/j.urology.2011.03.043.
5
A population based assessment of perioperative mortality after cystectomy for bladder cancer.基于人群的膀胱癌膀胱切除术后围手术期死亡率评估。
J Urol. 2009 Jul;182(1):70-7. doi: 10.1016/j.juro.2009.02.120. Epub 2009 May 17.
6
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.根治性膀胱切除术治疗非埃及血吸虫源性鳞状细胞癌与尿路上皮癌的生存比较:竞争风险分析。
BJU Int. 2012 Feb;109(4):564-9. doi: 10.1111/j.1464-410X.2011.10357.x. Epub 2011 Aug 2.
7
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.膀胱移行细胞癌根治性膀胱切除术的疗效:来自膀胱癌研究联盟的当代系列研究
J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004.
8
Contemporary 90-day mortality rates after radical cystectomy in the elderly.老年人根治性膀胱切除术后的当代90天死亡率
Eur J Surg Oncol. 2014 Dec;40(12):1738-45. doi: 10.1016/j.ejso.2014.10.004. Epub 2014 Oct 15.
9
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
10
High risk populations and cystectomy outcomes.高风险人群与膀胱切除术结果。
J Urol. 2009 Jul;182(1):10-1. doi: 10.1016/j.juro.2009.04.058. Epub 2009 May 17.

引用本文的文献

1
Radical cystectomy mortality in older patients: a systematic review and meta-analysis.老年患者根治性膀胱切除术的死亡率:一项系统评价和荟萃分析。
BJU Int. 2025 Jul;136(1):19-31. doi: 10.1111/bju.16733. Epub 2025 Apr 9.
2
Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer.多参数磁共振成像与人工智能在预测和监测膀胱癌治疗反应中的应用
Insights Imaging. 2025 Jan 2;16(1):7. doi: 10.1186/s13244-024-01884-5.
3
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.
膀胱癌中的性别二态性:病因、生物学、诊断及预后综述
Front Pharmacol. 2024 Jan 12;14:1326627. doi: 10.3389/fphar.2023.1326627. eCollection 2023.
4
Comparison of morbidity and mortality after radical cystectomy between individuals older and younger than 80 years: a systematic review and meta-analysis.80岁及以上与80岁以下个体根治性膀胱切除术后发病率和死亡率的比较:一项系统评价和荟萃分析。
Int Urol Nephrol. 2024 May;56(5):1525-1535. doi: 10.1007/s11255-023-03897-3. Epub 2023 Dec 14.
5
Ileal conduit versus single stoma uretero-cutanoustomy after radical cystectomy in patients ≥ 75 years; which technique is better? a prospective randomized comparative study.根治性膀胱切除术后≥75 岁患者行回肠膀胱与单造口输尿管皮肤造口术的比较:哪种技术更好?一项前瞻性随机对照研究。
Int Urol Nephrol. 2023 Jul;55(7):1719-1726. doi: 10.1007/s11255-023-03609-x. Epub 2023 May 3.
6
Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients.丝裂霉素C膀胱内热化疗治疗高危非肌层浸润性膀胱癌患者
BJUI Compass. 2022 Dec 2;4(3):314-321. doi: 10.1002/bco2.203. eCollection 2023 May.
7
Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review.肌肉浸润性膀胱癌的综合保膀胱治疗:我们(应该)如何进行?一项叙述性综述。
J Clin Med. 2023 Feb 16;12(4):1560. doi: 10.3390/jcm12041560.
8
Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study.老年肌层浸润性膀胱癌患者根治性膀胱切除术后的并发症与出院情况:ELCAPA - 27队列研究
Cancers (Basel). 2021 Nov 29;13(23):6010. doi: 10.3390/cancers13236010.
9
Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer.性甾体激素受体状态在尿路上皮膀胱癌中的临床及治疗意义
Indian J Urol. 2020 Jul-Sep;36(3):171-178. doi: 10.4103/iju.IJU_320_19. Epub 2020 Jul 1.
10
Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma.年轻患者的肌层浸润性膀胱癌发生淋巴结转移的风险增加。
BMC Cancer. 2020 Sep 4;20(1):851. doi: 10.1186/s12885-020-07354-7.